![ASAP] Design and Synthesis of Novel Spiro Derivatives as Potent and](https://s3-eu-west-1.amazonaws.com/stackademic/production/paper/7759013.png "ASAP] Design and Synthesis of Novel Spiro Derivatives as Potent and")
ASAP] Design and Synthesis of Novel Spiro Derivatives as Potent and
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Molecules | Free Full-Text | Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
Structural modifications of MAGL inhibitor 144. | Download Scientific Diagram
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses | Molecular Psychiatry
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Monoacylglycerol Lipase Inhibitor 21 (MAGL Inhibitor 21, MGL Inhibitor 21, CAS Number: 1643657-35-5) | Cayman Chemical
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Representative MAGL inhibitors along with their IC 50 value. | Download Scientific Diagram
MJN110 is an Orally Active and Selective Monoacylglycerol Lipase Inhibitor - Immune System Research
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition - RSC Advances (RSC Publishing)
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine
MAGL Inhibitor III, JZL184 - CAS 1101854-58-3 - Calbiochem | 475741
MAGL Inhibitor Compound 23 (CAS Number: 2324160-91-8) | Cayman Chemical
![Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase](https://www.thno.org/v06/p1145/thnov06p1145g001.jpg "Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase")
Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase - Wikipedia
APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie International Edition - Wiley Online Library
